NCT03614455View on ClinicalTrials.gov

Pharmacokinetics (PK) Drug Interaction Study of Milademetan and Itraconazole or Posaconazole in Healthy Participants

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 13, 2018

Primary Completion Date

October 1, 2018

Study Completion Date

October 1, 2018

Conditions
Pharmacokinetics
Interventions
DRUG

Milademetan

Milademetan 100 mg capsule for oral administration

DRUG

Itraconazole

Itraconazole (200 mg) oral solution (20 mL of 10 mg/mL)

DRUG

Posaconazole

Posaconazole (200 mg) oral suspension (5 mL of 40 mg/mL)

Trial Locations (1)

75247

Covance Clinical Research Unit, Inc., Dallas

Sponsors

Lead Sponsor

Daiichi Sankyo
All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY